Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas

This publication has 23 references indexed in Scilit:

• A liver X receptor (LXR)-β alternative splicing variant (LXRBSV) is preferentially expressed in the pituitary
  Biochemical and Biophysical Research Communications, 2010
• A liver X receptor (LXR)-β alternative splicing variant (LXRBSV) acts as an RNA co-activator of LXR-β
  Biochemical and Biophysical Research Communications, 2009
• Cushing's disease
  Best Practice & Research Clinical Endocrinology & Metabolism, 2009
• Transcriptional Activation of the Mixed Lineage Leukemia–p27Kip1 Pathway by a Somatostatin Analogue
  Clinical Cancer Research, 2009
• Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
  The Journal of Clinical Endocrinology & Metabolism, 2008
• Liver X receptors regulate adrenal cholesterol balance
  Journal of Clinical Investigation, 2006
• The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse
  Journal of Lipid Research, 2003
• Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas
  Nature Medicine, 2002
• Oxysterols
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
• A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.
  Molecular and Cellular Biology, 1994